Different recommendations for daptomycin dosing over time in patients with severe infections.

TO THE EDITOR—We thank Sachdev et al for their interest in and evaluation of our article [1]. The respondents present data from a survey of providers in metropolitan areas with the highest human immunodeficiency virus incidence, and their results complement and support our findings. Unlike our article, which specifically surveyed infectious disease physicians, the respondents captured responses from primary care providers. Their results demonstrate that provider self-efficacy and normative beliefs about preexposure prophylaxis (PrEP) were associated with intention to prescribe PrEP. These data build on our findings that complex and multiple barriers exist to the provision of PrEP among both infectious disease specialists and primary care providers. In addition, their work supports our conclusion that multifaceted approaches will likely be necessary to the successful provision of real-world PrEP.